Parkside Financial Bank & Trust’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-95	Closed	–	–	1783
2020 Q1	$0	Sell	95 -34	-26%	-$146	﹤0.01%	1749
2019 Q4	$1K	Hold	129	–	–	﹤0.01%	1555
2019 Q3	$1K	Buy	129 +20	+18%	+$100	﹤0.01%	1532
2019 Q2	$1K	Hold	109	–	–	﹤0.01%	1548
2019 Q1	$1K	Sell	109 -8	-7%	-$36	﹤0.01%	1502
2018 Q4	$0	Buy	117 +59	+102%	+$300	﹤0.01%	1642
2018 Q3	$0	Buy	+58	New	+$446	﹤0.01%	1659
2017 Q4	–	Sell	-42	Closed	–	–	1554
2017 Q3	$0	Hold	42	–	–	﹤0.01%	1594
2017 Q2	$0	Buy	42 +11	+35%	+$81	﹤0.01%	1603
2017 Q1	$0	Buy	+31	New	+$309	﹤0.01%	1577

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Parkside Financial Bank & Trust's PGNX Position: Q2 2020 in Review

Parkside Financial Bank & Trust sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 95 shares.

Parkside Financial Bank & Trust first reported a position in PGNX in Q1 2017 and held it in 10 quarters. The position peaked at $1K in Q4 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Parkside Financial Bank & Trust reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Parkside Financial Bank & Trust sold 95 Progenics Pharmaceuticals Inc shares in Q2 2020.
Parkside Financial Bank & Trust first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 10 quarters.
Parkside Financial Bank & Trust's Progenics Pharmaceuticals Inc position peaked at $1K in Q4 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2020, filed 10 Aug 2020.